ATXS vs DHI · rev $706.0K vs P/E 9.6, rev $34.25B
Astria Therapeutics Inc (ATXS) versus DR Horton Inc (DHI) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
DR Horton Inc (DHI) is a residential construction company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
ATXS currently screens at market cap $382.1M. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Not investment advice. Open the ATXS and DHI stock pages for the full models.
Not investment advice.